Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.
about
miRNome in myocardial infarction: Future directions and perspectiveSafe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse EffectsExercise training reduces resting heart rate via downregulation of the funny channel HCN4Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation.Ivabradine Prevents Low Shear Stress Induced Endothelial Inflammation and Oxidative Stress via mTOR/eNOS Pathway.Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissuePleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain.Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat.Treatment of inappropriate sinus tachycardia with ivabradine.Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.HCN Channels Modulators: The Need for Selectivity.Heart rate reduction in coronary artery disease and heart failure.Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.Anacardic acid and thyroid hormone enhance cardiomyocytes production from undifferentiated mouse ES cells along functionally distinct pathways.Analysis of decreases in systemic arterial pressure and heart rate in response to the hydrogen sulfide donor sodium sulfide.
P2860
Q27028108-70283B10-F5AE-44B2-9F9E-853687BBC782Q31059046-D52C07DA-A8FC-462C-A593-BEC0C11CCABDQ33626667-DBD51E7B-D2F1-42E3-B26C-080A9B131E03Q35919665-B8612DAB-9506-466D-B8F6-EFF2FE5065B0Q35927302-0471C2C9-53DE-40D5-B352-D5CF3D1130A9Q36159185-44E85E3B-9CAA-472A-A6F3-7F8520B0AC12Q37988319-5F4FD6E0-0573-491B-92E6-D26660CC0B3DQ38142792-292797C6-3AC8-499E-86D2-B4DC4C922627Q38547852-38F86E43-BE6D-4EB5-B3E9-9E63C2AD3569Q38607203-BFA148AE-157B-450C-A4D2-AEC628A0E14FQ38621386-139892DA-E0EC-4BDC-A96E-2CF76FF0898BQ38774251-F54F1F73-C672-4106-BD40-71123BCFD42CQ38844531-60F61150-8953-4B33-8279-F57F2D7A96D5Q46031161-169A4D2E-FF54-46E2-87E7-616DE282C7B5Q46222726-625ACEE9-012B-416F-82EC-F25748CDB8BDQ47622945-A563DE8F-CB43-447C-892A-1C7CA4F554D0Q47846860-1F0F4A23-A3E4-4678-A324-96758B394E76
P2860
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Long-term treatment with ivabr ...... acts f-channel overexpression.
@ast
Long-term treatment with ivabr ...... acts f-channel overexpression.
@en
type
label
Long-term treatment with ivabr ...... acts f-channel overexpression.
@ast
Long-term treatment with ivabr ...... acts f-channel overexpression.
@en
prefLabel
Long-term treatment with ivabr ...... acts f-channel overexpression.
@ast
Long-term treatment with ivabr ...... acts f-channel overexpression.
@en
P2093
P2860
P50
P1476
Long-term treatment with ivabr ...... acts f-channel overexpression.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2011.01627.X
P407
P577
2012-03-01T00:00:00Z